The introduction of additional aPL as well as TGA measurements into laboratory practice could be a useful tool to refine and speed up the diagnosis of APS or the identification of patients at risk and the manifestation of thrombotic complications in APS. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.